Long-acting psychiatry
Nao Medical can evaluate adults who are considering a long-acting psychiatric injection and can review an outside prescriber's order. An evaluation does not guarantee an injection. The responsible prescriber, medicine, dose, initiation history, due date, patient-specific delivery, trained staff, and administration site must all be confirmed before an injection visit.
Schizophrenia treatment can combine antipsychotic medicine, psychological and family support, and help with daily activities. A long-acting injection may suit a person’s preference or difficulty taking tablets, but it is not automatically the best option. Products differ in indication, route, interval and start rules. Prescribing, administration, monitoring and ongoing psychiatric care must stay connected. The longest interval is not a first-step choice for everyone. Treatment-resistant illness may warrant a clozapine assessment rather than another routine injection change.
Schizophrenia care can combine antipsychotic medicine with psychotherapy, family education, practical support and help with daily activities. Some antipsychotics are available as long-acting injections. An injection can be useful when a person prefers that form or has difficulty with daily medicine, but it is not automatically the best choice. A medication programme should connect prescribing, administration and continuing psychiatric care.
Antipsychotics affect brain receptor systems involved in psychosis. A long-acting formulation gradually releases medicine after an injection. Different products use different ingredients, routes, intervals and release patterns. Some need oral medicine at the start, some use an initiation sequence and some require previous stabilization on a shorter-interval injection. These differences determine the safe plan.
The psychiatrist reviews diagnosis, previous response, tolerability, physical health, preferences and practical needs. The indication differs by product: some cover adult schizophrenia only; others have specific schizoaffective or bipolar maintenance indications. The longest dosing interval is not a first-step option for every patient. Treatment-resistant schizophrenia may call for a clozapine assessment rather than another routine injection change.
Discuss daily-pill difficulties, benefits, adverse effects, injection preferences, work and transport. Review the actual label, prior trials and alternatives without treating an injection as a reward or punishment.
The administering team needs the exact product, strength, last date, route, oral coverage and responsible prescriber. A discharge note saying “monthly antipsychotic” is insufficient. Resolve product delivery and any late-dose plan before the appointment.
Record what was given and when the next dose is due. Share the record with the prescribing clinician. Continuing reviews cover symptoms, daily function, movement effects, metabolic health, prolactin where relevant and psychosocial needs.
Bring the exact product name, prescribed strength, last injection date, oral medicine list and the responsible prescriber’s contact information. Include discharge notes, recent blood tests and any written start or restart plan. Tell the team about pregnancy, breastfeeding, allergies, seizures, fainting, substance use and new medicines or supplements. If a dose is delayed or records are unclear, contact the prescriber before travelling to an administration visit. Discuss who can help with appointment reminders or transport if you want that support. Ask how consent, preferences and questions about a longer-lasting treatment will be addressed.
Antipsychotics have a boxed warning about increased mortality in older adults with dementia-related psychosis. Product-specific risks include movement symptoms, sedation, falls, weight and metabolic changes, prolactin effects and sometimes heart-rhythm concerns. Effects of a depot cannot be immediately removed after an injection. Seek emergency care for severe trouble breathing, throat or tongue swelling, loss of consciousness, or high fever with severe muscle stiffness and confusion. Contact the treating team promptly for new involuntary movements, severe restlessness, worsening psychosis, marked dizziness or troublesome injection-site symptoms. Do not wait for the next routine injection to report a serious concern. Report worsening psychosis or safety concerns promptly rather than waiting for the injection date.
Arrange both injection appointments and psychiatric reviews. If a dose may be missed, contact the responsible prescriber with the exact product, strength and last date. Restart rules vary. Report side effects between doses. Ask about therapy, family support, housing, work or coordinated specialty care when relevant. A reliable injection schedule is one part of a broader care plan.
Before an injection appointment, ask which clinic can accept the prescription, how the medicine will be obtained, and which costs belong to the medicine, administration and psychiatry follow-up. A benefits check, prior authorization and medicine delivery are different steps. Ask for the proposed cost before each step. Manufacturer assistance has its own eligibility rules. Office-visit coverage does not establish medication coverage, and a listed clinic does not establish that the product is stocked or can be given there today. Confirm whether Nao is providing prescribing, administration under an outside order or both. The responsibilities and records should be clear before transfer of care.
Nao Medical can coordinate psychiatric injection care with your prescribing psychiatrist. Share the current order, exact medicine, last dose date and treatment history through the confirmed clinical intake process. The clinicians review product-specific initiation or restart requirements and arrange medication delivery, administration and follow-up. Keep your existing treatment plan until the next appointment is agreed.
Ask the selected service for the next available appointment for injection-treatment assessment. Confirm whether booking or a walk-in visit is appropriate before traveling. The first visit reviews eligibility, records and the treatment plan. Medication delivery, authorization and an injection appointment may need separate coordination.
Confirm which psychiatric injections the prescribing clinician and administration site can provide before booking. Ask intake which exact products, indications and start/maintenance regimens the clinician and administering site accept. Aripiprazole, paliperidone and risperidone have long-acting products with different labels. These medicines and formulations are not interchangeable. Send the product, strength, last date and prescriber's order before assuming a general psychiatric-injection appointment fits.
Ask which exact clinic and body site the prescribed product uses. The administering location must accept the order, receive the medicine and have the qualified clinician available. Injection route and body site differ by formulation. A generic 'monthly injection' description is insufficient. Confirm the product, strength, last date and any initiation or late-dose instructions with the prescriber before attendance.
Contact the prescribing team with the exact product, dose, last injection date and current symptoms. Each formulation has its own missed-dose thresholds and may require an oral bridge or repeat initiation steps. A late dose does not justify doubling, converting or using another product yourself. Confirm the written restart order, sourcing and appointment. Returning psychosis or unsafe behavior needs prompt clinical assessment.
A switch needs the responsible psychiatrist's documented plan, not just an administration appointment. Review the exact current product, strength, last dose, response and tolerability. The new injection has its own indication, prior-treatment, loading or oral-coverage rules. Ask whether Nao provides the prescribing evaluation or accepts an outside order, and confirm delivery, the administering site and follow-up before changing treatment. Do not stop or convert medicines yourself.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
Bring the exact product name, prescribed strength, last injection date, oral medicine list and the responsible prescriber’s contact information. Include discharge notes, recent blood tests and any written start or restart plan. Tell the team about pregnancy, breastfeeding, allergies, seizures, fainting, substance use and new medicines or supplements. If a dose is delayed or records are unclear, contact the prescriber before travelling to an administration visit. Discuss who can help with appointment reminders or transport if you want that support. Ask how consent, preferences and questions about a longer-lasting treatment will be addressed.
Discuss daily-pill difficulties, benefits, adverse effects, injection preferences, work and transport. Review the actual label, prior trials and alternatives without treating an injection as a reward or punishment.
The administering team needs the exact product, strength, last date, route, oral coverage and responsible prescriber. A discharge note saying “monthly antipsychotic” is insufficient. Resolve product delivery and any late-dose plan before the appointment.
Record what was given and when the next dose is due. Share the record with the prescribing clinician. Continuing reviews cover symptoms, daily function, movement effects, metabolic health, prolactin where relevant and psychosocial needs.
Confirm whether an outside psychiatrist is prescribing and managing treatment or whether Nao psychiatry should evaluate and manage the plan. Review symptoms, diagnosis, current and prior medicines, adherence, side effects, and treatment goals.
The responsible prescriber confirms the medicine, dose, initiation or oral-overlap requirements, due date, and any needed laboratory or physical monitoring.
Nao reviews order acceptance, benefits, patient-specific delivery, medication arrival, trained staff, and the eligible administration clinic.
The team documents the dose, observes as required, communicates with the prescriber, and plans follow-up and the next due date.
Bronx
932 E 174th St, Bronx, NY 10460
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Queens
37-15 23rd Ave, Astoria, NY 11105
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Bronx
2063A Bartow Ave, Bronx, NY 10475
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Queens
30-07 36th Ave, Astoria, NY 11106
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Long Island
135 Mineola Blvd, Mineola, NY 11501
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Manhattan
259 1st Ave, New York, NY 10003
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
If an outside psychiatrist manages treatment, send the order and records for Nao review. If not, Nao psychiatry can evaluate and manage the plan. Medication delivery, trained staff, and the administration site must be confirmed before travel.
Understand the one-time initiation regimen used with Aristada when clinically appropriate.
Review the two-week risperidone injection pathway and oral-coverage requirement.
Review the manufacturer discontinuation notice and prepare a prescriber-led continuity plan. Perseris is not presented as a currently bookable injection.
Connect injection decisions with diagnosis, monitoring, and longitudinal care.
Review the high-accountability oral treatment pathway and current ANC requirements.
Review Abilify Maintena initiation, monitoring, access, and missed-dose questions.
Review Invega Sustenna initiation, monitoring, access, and missed-dose questions.
American Psychiatric Association
Assessment, antipsychotic treatment, long-acting medicines, clozapine, and monitoring.
Open official sourceAmerican Psychiatric Association
Psychiatric, treatment, substance-use, medical, safety, and shared-decision assessment.
Open official sourceU.S. Food and Drug Administration
Current active REMS status and official program materials.
Open official sourceContent was updated August 12, 2026 using the sources cited above. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.